| Literature DB >> 36110961 |
Nattida Kampuang1, Narongrit Thongon1.
Abstract
Disruption of small intestinal Mg2+ absorption has been reported as the underlying mechanism of proton pump inhibitor-induced hypomagnesemia (PPIH); hence, this study evaluated the expression, localization, phosphorylation, and oxidation of transient receptor potential melastatin 6 (TRPM6) and TRPM7 in the small intestine of rats subjected to PPIH. The expression and localization of cyclin M4 (CNNM4) was also analyzed. We show that, compared to control rats, membrane expression of the TRPM6/7 heterodimer and TRPM7 was markedly lower in the duodenum and the jejunum of PPIH rats; in contrast, expression of membrane TRPM6 and CNNM4 was higher in these organs. Mass spectrometric analysis of TRPM6 demonstrated hyper-phosphorylation, especially T1851, and hyper-oxidation at M1755, both of which can suppress its channel permeability. Further, hypo-phosphorylation of S141 and the dimerization motif domain of TRPM6 in PPIH rats might be involved in lower TRPM6/7 heterodimer expression. Hypo-phosphorylation, especially at S138 and S1360 in TRPM7 from PPIH rats disrupted stability of TRPM7 at the cell membrane; hyper-oxidation of TRPM7 was also observed. These results help explain the mechanism underlying the disruption of small intestinal Mg2+ absorption in PPIH.Entities:
Keywords: TRPM6; TRPM7; hypomagnesemia; oxidation; phosphorylation; proton pump inhibitors; small intestine
Year: 2022 PMID: 36110961 PMCID: PMC9468766 DOI: 10.3389/fonc.2022.947899
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Figure 1Total TRPM6 (A), TRPM7 (B), and CNNM4 (C) expression in duodenum, jejunum, ileum, and colon of control or omeprazole treated rats. ome; omeprazole. *P < 0.05, **P < 0.01, ***P < 0.001. (n = 6).
Figure 2Membrane TRPM6 (A) and cytosolic TRPM6 (B) expression in duodenum, jejunum, ileum, and colon of control or 12 wk omeprazole-treated rats. Membrane TRPM6 (C) and cytosolic TRPM6 (D) expression in duodenum, jejunum, ileum, and colon of control or 24 wk omeprazole-treated rats. The upper relative expression graph; the protein expression in jejunum, ileum, and colon was relatively compared to that of in the duodenum. The lower relative expression graph; the protein expression in duodenum, jejunum, ileum, and colon of omeprazole-treated groups was relatively compared its corresponding segment of control group. Duo, duodenum; Jeju, jejunum; Ile, ileum; Co, colon; ome, omeprazole. *P < 0.05, **P < 0.01, ***P < 0.001. (n = 6).
Figure 3Membrane TRPM7 (A) and cytosolic TRPM7 (B) expression in duodenum, jejunum, ileum, and colon of control or 12 wk omeprazole-treated rats. Membrane TRPM7 (C) and cytosolic TRPM7 (D) expression in duodenum, jejunum, ileum, and colon of control or 24 wk omeprazole-treated rats. The upper relative expression graph; the protein expression in jejunum, ileum, and colon was relatively compared to that of in the duodenum. The lower relative expression graph; the protein expression in duodenum, jejunum, ileum, and colon of omeprazole-treated groups was relatively compared its corresponding segment of control group. Duo, duodenum; Jeju, jejunum; Ile, ileum; Co, colon; ome, omeprazole. *P < 0.05, **P < 0.01, ***P < 0.001. (n = 6).
Figure 4Membrane TRPM6 and TRPM7 expression from immunoprecipitated (IP)-TRPM6 sample from duodenal and ileal tissues of control or omeprazole-treated rats. Duo, duodenum; Jeju, jejunum. **P < 0.01, ***P < 0.001. (n = 6).
Figure 5Membrane CNMM4 (A) and cytosolic CNMM4 (B) expression in duodenum, jejunum, ileum, and colon of control or 12 wk omeprazole-treated rats. Membrane CNMM4 (C) and cytosolic CNMM4 (D) expression in duodenum, jejunum, ileum, and colon of control or 24 wk omeprazole-treated rats. The upper relative expression graph; the protein expression in jejunum, ileum, and colon was relatively compared to that of in the duodenum. The lower relative expression graph; the protein expression in duodenum, jejunum, ileum, and colon of omeprazole-treated groups was relatively compared its corresponding segment of control group. Duo, duodenum; Jeju, jejunum; Ile, ileum; Co, colon; ome, omeprazole. *P < 0.05, **P < 0.01, ***P < 0.001. (n = 6).
Phosphorylated residue of TRPM6 protein from duodenum and jejunum of control or omeprazole-treated rats.
| Duodenal TRPM6 protein | Jejunal TRPM6 protein | |||||
|---|---|---|---|---|---|---|
| control | 12-wk omeprazole | 24-wk omeprazole | control | 12-wk omeprazole | 24-wk omeprazole | |
|
| S12, S67, S78, Y80, | S12, S32, T94, Y111, | S12, S15, S28, S32, | S15, Y31, S78, S82, | T28, S32, S33, Y66, | S15, T28, S32, S67, |
|
| Y878, 915, T936, | S876, T881, S893, | S876, Y878, T881, | S876, Y878, T881, | Y878, T881, T899, | T881, S893, T899, |
|
| Y1073, S1078, Y1086, | Y1073, S1078, S1080, | Y1073, S1078, S1080, | Y1073, S1078, S1080, | Y1073, S1078, T1094, | Y1073, 1078, S1080, |
|
| Y1137, S1139, Y1157 | S1139, Y1157, S1168 | S1139, S1168 | Y1137, S1139, Y1157, | Y1137, Y1157 | Y1137, S1168 |
|
| T1176, S1177, T1181, | T1176, T1181, T1184, | T1176, T1181, S1216 | T1176, S1177, T1181, | S1200, S1203, S1206, | S1200, S1203, S1206, |
| T1231, | T1231, S1244, T1245, | T1231, T1240, S1244, | S1226, T1230, S1244, | S1226, S1244, S1254, | S1244, Y1275, S1277, | |
|
| S1438, S1441, S1458, | T1435, S1437, S1467, | T1435, S1437, S1458, | Y1452, T1463, S1467, | S1428, T1430, T1435, | S1428, T1430, T1435, |
|
| Y1710, S1711, S1722, | Y1710, S1711, T1724 | S1711 | Y1710, S1711, S1722, | Y1710, S1711 | Y1710, S1711 |
| S1736, S1737, T1739, | Y1741 | Y1741 | S1737, T1739, Y1741, | S1746, S1747 | S1746 | |
|
| S1754, S1757, S1821, | S1754, S1759, S1771, | S1754, S1757, S1759, | S1754, S1756, S1771, | S1754, S1756, S1757, | S1754, S1756, S1757, |
| S1986, T1993, T2011 | S1970, Y1984, T1992, | S1970, S2002, T2011, | S1970, Y1985, S1986, | S1970, Y1985, S1986, | S1970, Y1985, S1986, | |
The highlighted residues have been previously reported to affect TRPM6 activity.
Phosphorylated residue of TRPM7 protein from duodenum and jejunum of control or omeprazole-treated rats.
| Duodenal TRPM7 protein | Jejunal TRPM7 protein | |||||
|---|---|---|---|---|---|---|
| control | 12-wk omeprazole | 24-wk omeprazole | control | 12-wk omeprazole | 24-wk omeprazole | |
|
| S9, T10, T12, Y18, | T12, T55, S57, Y62, | T12, S22, S23, T55, | S2, Y18, S22, S23, | Y18, S23, T55, T60, | Y18, T55, S57, T60, |
|
| Y892, T895, Y896, | Y896, T929, S934, | S907, S913, Y949, | S913, S921, S929, | S883, S907, S913, | Y923, T929, S934, |
|
| Y1100, S1107, Y016, | Y1100, S1107, Y1016, | Y1100, S1107, S1036, | Y1100, S1107, Y1116, | S1107, Y1113, Y1116 | S1136 |
|
| T1154, S1155, T1163, | S1155, T1163, Y1181 | T1154, S1155 | S1155, T1163, Y1181, | S1155, T1163, S1193 | S1155 |
|
| T1200, S1208, S1224, | T1200, S1208, Y1220, | S1208, Y1220, S1224, | T1200, Y1220, S1224, | T1200, S1208, Y1220, | S1227, T1245, T1248, |
| S1255, S1258, T1265, | S1255, S1300, Y1326, | S1255, S1258, T1265, | S1255, S1258, S1271, | S1258, T1265, S1269, | S1258, S1299, S1300, | |
|
| S1386, S1389, S1390, | S1385, S1386, S1389, | S1385, S1386, S1389, | S1386, S1389, S1390, | S1386, S1389, S1390, | S1390, S1394, S1395, |
|
| S1553, S1564, S1566 | S1553, S1564, S1566 | S1553, S1564, S1566 | Y1552, S1564, S1566 | Y1552, S1564, S1566 | Y1552, S1564, S1566 |
| S1587, S1888, S1590 | Y1582, S1590 | Y1582, S1590 | T1580, S1587, S1588, | S1587, S1588 | Y1582, S1588 | |
|
| S1595, S1597, S1598, | S1595, S1597, S1598, | S1595, S1597, S1598, | S1592, S1598, S1600, | S1598, S1595, S1597 | S1598, T1629, S1631, |
| Y1826, T1827, S1839, | Y1826, T1827, S1839, | T1827, S1839, | T1827, S1839, S1848, | T1827, S1838, S1839, | T1827, S1838, S1839 | |
The highlighted residues have been previously reported to affect TRPM6 activity.
Methionine oxidation in TRPM6 protein from duodenum and jejunum of control or omeprazole-treated rats.
| control | 12-wk omeprazole | 24-wk omeprazole | |
|---|---|---|---|
|
| M33, M63, M133, M338, | M1, M33, M63, M133, | M1, M33, M63, M127, |
|
| M127, M133, M151, M263, | M1, M127, M133, M151, | M1, M127, M133, M151, |
The highlighted residues have been previously reported to affect TRPM6 activity.
Methionine oxidation in TRPM7 protein from duodenum and jejunum of control or omeprazole-treated rats.
| control | 12-wk omeprazole | 24-wk omeprazole | |
|---|---|---|---|
|
| M43, M372, M595, | M130, M143, M369, | M1, M130, M130, |
|
| M130, M369, M372, | M1, M130, M372 | M1, M43, M130, |